Clinical Trial Update: Flushing in Social Anxiety Disorder on Cipralex [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating flushing in patients with Social Anxiety Disorder treated with escitalopram (Cipralex); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• Cipralex (citalopram)

Snippet

Sponsor: START Clinic for Mood and Anxiety Disorders | Conditions: Social Anxiety Disorder | Phase 2 | Status: COMPLETED